Understanding aHUS: Why Early and Accurate Diagnosis Matters

Atypical hemolytic uremic syndrome (aHUS) is a rare but serious condition that affects the blood and kidneys. Because its symptoms can look like several other illnesses, diagnosing it correctly—and quickly—is very important for saving kidney function and even lives.

This article summarizes key insights from experts in nephrology (kidney specialists) and genetics on how aHUS is diagnosed and managed.

What is aHUS?

aHUS is a disease where small blood clots form in tiny blood vessels, especially in the kidneys. This leads to three main problems:

Destruction of red blood cells (anemia)
Low platelet counts (affecting clotting)
Kidney injury

Most cases of aHUS are caused by problems in the body’s complement system, a part of the immune system that helps fight infections. When this system becomes overactive, it can damage the body’s own blood vessels.

Why is Diagnosis Difficult?

The symptoms of aHUS are similar to many other conditions, such as:

Severe infections (like sepsis or dengue)
A related condition called TTP
Diarrhea-related HUS (common in some countries)
Autoimmune diseases

Because of this, doctors must first rule out these other conditions before confirming aHUS.

How Do Doctors Diagnose aHUS?

Doctors follow a step-by-step approach:

Rule out infections and common causes

Tests are done for infections like malaria, dengue, or bacterial illnesses.
Check for related conditions

Special tests may be needed to rule out TTP or rare metabolic disorders.
Look for complement system problems

Blood tests help identify abnormalities in the immune system.
Test for antibodies and genes
- In many Indian patients, the disease is caused by antibodies against a protein called factor H.
- Genetic testing may also be done to identify inherited causes.

Importantly, doctors may start treatment before all test results are available, because delays can worsen outcomes.

Treatment Options

1. Plasma Exchange (Common in India)

This procedure removes harmful substances (like antibodies) from the blood and replaces them with healthy plasma. It is often started urgently.

2. Targeted Medicines

In many countries, drugs that block the complement system (such as eculizumab) are the standard treatment. These drugs can dramatically improve outcomes, but access may be limited in some regions.

Why Early Treatment is Crucial

Experts strongly emphasize that treatment should begin within 24 hours of suspicion. Early treatment can:

Prevent permanent kidney damage
Reduce the need for dialysis
Improve survival

What Makes India Different?

In India, a large number of children with aHUS have a specific type caused by anti-factor H antibodies. This is important because:

It is treatable with plasma exchange and medicines
Outcomes can be good if treated early

The Importance of Teamwork

Managing aHUS requires a team approach:

Nephrologists diagnose and treat kidney problems
Geneticists help interpret genetic tests
Laboratories ensure accurate testing

Working together helps doctors choose the best treatment and prevent relapses.

Key Takeaways

aHUS is rare but serious—early diagnosis is critical.
Symptoms can mimic other illnesses, so careful testing is needed.
Treatment should start quickly, even before all results are confirmed.
Many cases in India are treatable if identified early.

Saturday, April 4, 2026

Summary for patients of recent meeting between nephrologists and geneticists on optimising aHUS Diagnosis